GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is the Highmark Distinguished Professor in the Institute for Complex and Engineered Systems at Carnegie Mellon University. He is also the executive director of the Pittsburgh Tissue Engineering Initiative and the director of the National Tissue Engineering Center.
Dr. Russell was the founding director of the McGowan Institute for Regenerative Medicine, jointly established by the University of Pittsburgh School of Medicine and UPMC Health System as a center of expertise and education in therapies that reestablish tissue and organ function. The McGowan Institute is a center for research and clinical work in tissue engineering, adult-derived stem cell research and cellular therapies, biosurgery, and artificial and biohybrid organ devices. He was also founding president of the 3,000-member Tissue Engineering and Regenerative Medicine International Society.
He has given more than 250 national and international invited lectures. He holds 14 patents and has 23 patents pending.
More GEN Content From This Contributor:
- Biopharmaceutical: Alan J. Russell, Ph.D.
- Biopharmaceutical: <i>Disruptive Science and Technology</i>: A New Journal
- Columns: Disrupting Alzheimer’s Disease Research